The course of action:

Pharmaceutical company Pfizer wanted to develop a medicine for angina, chest pains and high blood pressure – a great intention. Pfizer invested in and carried out clinical trials for 6 years under the leadership of Ian Osterloh. As far as is known the research was carried out properly and there were no mishaps. Except…

The result:

After 6 years it became clear that the medicine did not have the desired effects. However, many patients reported erections and improved potency as side effects.

The lesson:

Pfizer radically changed strategy and tested the new medicine against erection disorders.

Further:
Today, every second, someone somewhere is taking a Viagra pill.

Published by:
Redactie IVBM

OTHER BRILLIANT FAILURES

The Museum of Failed Products

Robert McMath - a marketing professional - intended to accumulate a reference library of consumer products. The course of action was Starting in the 1960s he started to purchase and preserve a sample of every [...]

The Norwegian Linie Aquavit

The course of action: The concept of Linie Aquavit happened by accident in the 1800s. Aquavit (pronounced 'AH-keh'veet' and sometimes spelled "akvavit") is a potato-based liquor, flavored with caraway. Jørgen Lysholm owned a Aquavit distillery in [...]

F.A.I.L. First attempt in learning for start ups

Innovation is trying out without knowing the outcomes You can learn from failures, but it takes courage and an open dialogue. On autopsy.io you can find a whole series of start-ups that have not [...]

Why failure is an option..

Contact us for lectures and courses

SEND A MESSAGE

Or call Paul Iske +31 6 54 62 61 60 / Bas Ruyssenaars +31 6 14 21 33 47

2019-02-12T10:57:26+02:00
Instituut voor Briljante mislukkingen